20 Mar 2023 07:00
RNS Number : 4426T
Graft Polymer (UK) PLC
20 March 2023
20 March 2023
Graft Polymer (UK) Plc
("Graft Polymer", the "Company", and together with its subsidiaries, the "Group")
New Corporate Presentation
Graft Polymer (UK) Plc (LSE: GPL), a business focused on the development and commercial production of polymer modification, biological supplements, and nano-drug delivery systems, is pleased to announce that an updated corporate presentation is now available on its website: https://graftpolymer.com/.
**ENDS**
For more information, please visit https://www.graftpolymer.com or contact:
Graft Polymer (UK) Plc | via St Brides Partners |
Roby Zomer, Chairman |
|
Yifat Steuer, CFO |
|
|
|
Turner Pope Investments (Broker) | +44 20 3657 0050 |
James Pope |
|
Andy Thacker |
|
|
|
St Brides Partners (Public Relations) |
|
Catherine Leftley | graftpolymer@stbridespartners.co.uk |
Ana Ribeiro Max Bennett |
|
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRAJLMRTMTABBTJ
Sign In
Follow the stocks
